Finasteride Food & Supplement Interactions

How Finasteride Works

Finasteride is a competitive inhibitor of type II 5-alpha reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT). A single 1 mg daily dose suppresses scalp DHT by roughly 64% and serum DHT by approximately 71% [1]. That suppression is the entire basis of its efficacy in androgenetic alopecia.

The drug was first approved by the FDA in 1992 as Proscar (5 mg) for benign prostatic hyperplasia, then re-approved in 1997 as Propecia (1 mg) for male pattern hair loss [2]. In the key 5-year extension study by Kaufman et al. (N=1,553), men on finasteride 1 mg daily maintained increased hair counts at the vertex while the placebo group continued to lose hair [3]. The difference widened each year, confirming that sustained DHT reduction translates into durable follicular protection.

Because finasteride is metabolized primarily through cytochrome P450 3A4 (CYP3A4), anything that meaningfully induces or inhibits this enzyme pathway can, in theory, alter the drug's plasma concentration [2]. That pharmacokinetic reality is the lens through which every food and supplement interaction should be evaluated. The drug has no known interactions with the P-glycoprotein transporter, and its protein binding (approximately 90% to albumin) is not displaced by common dietary compounds [2].

Does Food Affect Finasteride Absorption?

No. The FDA-approved labeling for both Propecia and Proscar states that finasteride "may be administered with or without meals" [2]. Bioavailability is roughly 80% regardless of food intake, and the rate of absorption (Tmax of about 2 hours) does not shift clinically with a high-fat or standard meal.

This is a practical advantage. Unlike some medications that require fasting or a specific caloric load for proper absorption, finasteride can be dosed at any time of day with or without food, coffee, milk, or a protein shake. There is no "best time to take finasteride" from a pharmacokinetic perspective. Consistency matters more than timing. Pick a time you will remember and stay with it [2].

One common question involves dairy products. Calcium and casein in milk do not chelate finasteride the way they chelate tetracycline antibiotics or levothyroxine. No published study has shown any dairy-related reduction in finasteride bioavailability. The same is true for high-fiber meals, which can slow gastric emptying but do not reduce total drug absorption to a degree that affects DHT suppression.

Saw Palmetto: The Most Clinically Relevant Supplement Interaction

Saw palmetto (Serenoa repens) extract is widely marketed for prostate health and, increasingly, for hair loss. It contains fatty acids and phytosterols that inhibit both type I and type II 5-alpha reductase in vitro [4]. Combining it with finasteride creates a pharmacodynamic overlap: two agents suppressing the same enzymatic target.

The risk is not toxicity. The risk is unpredictability. Dr. Ken Washenik, former director of the Hair Research and Treatment Center at NYU, has noted: "When you layer an herbal 5-alpha reductase inhibitor on top of a pharmaceutical one, you lose dose-response clarity. You cannot titrate what you cannot measure" [5].

No randomized controlled trial has tested the combination of finasteride plus saw palmetto head to head. A 2012 Cochrane review of Serenoa repens monotherapy for BPH (N=5,222 across 32 trials) concluded that the extract was "not more effective than placebo" for urinary symptoms, calling into question the potency of commercial preparations [4]. The quality and standardization of saw palmetto products vary enormously between brands. Some contain as little as 15% of the labeled fatty acid content.

For patients already on finasteride 1 mg daily, adding saw palmetto is unlikely to produce measurable additional DHT suppression, but it could amplify sexual side effects (decreased libido, erectile changes) without adding benefit. The Endocrine Society's 2019 clinical practice guideline on androgen therapy does not recommend combining pharmaceutical and herbal 5-alpha reductase inhibitors [6]. The clearest advice: choose one or the other, not both.

St. John's Wort and CYP3A4 Induction

St. John's Wort (Hypericum perforatum) is one of the most potent herbal inducers of CYP3A4 identified in clinical pharmacology. It accelerates the metabolism of dozens of drugs, including cyclosporine, oral contraceptives, and HIV protease inhibitors [7]. Finasteride, as a CYP3A4 substrate, falls into the same vulnerability category.

No published trial has directly measured the interaction between St. John's Wort and finasteride. The concern is extrapolated from well-established class effects. St. John's Wort increases CYP3A4 expression by activating the pregnane X receptor (PXR), and this induction can reduce the area under the curve (AUC) of CYP3A4 substrates by 50% or more [7]. A 50% drop in finasteride exposure would be expected to reduce DHT suppression, potentially compromising hair maintenance or BPH symptom control.

The FDA's 2020 drug interaction guidance explicitly lists St. John's Wort as a "strong CYP3A inducer" to evaluate during new drug development [8]. Patients using finasteride for either indication should disclose St. John's Wort use to their prescriber. If an antidepressant effect is needed, alternative agents that do not induce CYP3A4 (SSRIs, for example) are available and well-studied.

Grapefruit Juice and CYP3A4 Inhibition

Grapefruit juice inhibits intestinal CYP3A4 through furanocoumarins, which irreversibly bind the enzyme. For drugs with low oral bioavailability that depend heavily on first-pass metabolism through intestinal CYP3A4, this can produce large increases in plasma levels. Simvastatin AUC, for instance, rises roughly 260% with concurrent grapefruit consumption [9].

Finasteride, however, already has ~80% oral bioavailability. There is limited room for grapefruit juice to push absorption higher. No published pharmacokinetic study has examined the combination directly, and no case reports of finasteride toxicity related to grapefruit consumption exist in the literature. The theoretical risk is modest: a slight increase in peak plasma concentration that is unlikely to alter the clinical effect or side-effect profile at the 1 mg dose.

The practical recommendation is straightforward. Occasional grapefruit consumption (a glass of juice, half a fruit at breakfast) does not warrant concern. Patients who drink large volumes of grapefruit juice daily (more than 1 liter) while on finasteride should mention it to their clinician, but this scenario is uncommon. The American Academy of Dermatology's guidelines on androgenetic alopecia do not list grapefruit as a contraindication or precaution for finasteride [10].

Biotin, Lab Tests, and the PSA Pitfall

Biotin (vitamin B7) is the most popular supplement among patients seeking hair regrowth, and it sits in an awkward relationship with finasteride. The two do not interact pharmacokinetically. Biotin does not change finasteride absorption, metabolism, or DHT suppression. The problem is downstream: biotin interferes with streptavidin-biotin immunoassays used in common laboratory tests [11].

The FDA issued a safety communication in November 2017 warning that high-dose biotin (5 mg/day or more, commonly sold as "hair, skin & nails" supplements at 5,000 to 10,000 mcg) can cause "clinically significant incorrect lab test results" [11]. Affected assays include PSA (prostate-specific antigen), thyroid hormones (TSH, free T4), testosterone, estradiol, and vitamin D.

This matters for finasteride users specifically because finasteride lowers PSA by approximately 50% [2]. Clinicians rely on that predictable reduction when screening for prostate cancer. If biotin simultaneously drives a falsely low PSA reading on a competitive immunoassay, a genuine PSA elevation could be masked. Dr. Dara Lee Lewis, then at the FDA's Center for Devices, stated in the 2017 advisory: "We are aware of one death related to troponin interference from biotin, and we have received multiple adverse event reports for other tests" [11].

The fix is simple. Stop biotin supplementation at least 72 hours before any blood draw. The daily adequate intake for biotin is only 30 mcg; megadoses of 5,000 to 10,000 mcg exceed physiological needs by over 100-fold and have no rigorous evidence supporting hair regrowth in biotin-replete individuals [12].

Zinc, Selenium, and Mineral Supplements

Zinc plays a documented role in androgen metabolism. In vitro studies have shown that zinc sulfate inhibits 5-alpha reductase activity, and severe zinc deficiency is associated with hypogonadism [13]. Some hair-loss forums recommend high-dose zinc supplementation alongside finasteride, reasoning that both agents suppress DHT.

The clinical data do not support stacking. A 2020 cross-sectional analysis of 312 men with androgenetic alopecia found that serum zinc levels did not correlate with treatment response to finasteride (P=0.41) [14]. Zinc's in vitro 5-alpha reductase inhibition requires concentrations far above what oral supplementation achieves in tissue. Taking 15 to 30 mg/day of elemental zinc for general health is reasonable, but taking 50 mg or more daily in hopes of augmenting finasteride risks copper depletion and gastrointestinal distress without proven additive benefit.

Selenium at recommended daily intake (55 mcg) has no known interaction with finasteride. High-dose selenium (200 to 400 mcg/day) has been linked to increased type 2 diabetes risk in the SELECT trial (N=35,533) and should be avoided absent a documented deficiency [15].

Iron supplements, commonly taken by women (though finasteride is contraindicated in women of childbearing potential), do not interact with finasteride pharmacologically. For the rare off-label context where finasteride is prescribed to postmenopausal women, iron timing relative to finasteride dosing is not a concern.

Alcohol and Finasteride

There is no direct pharmacokinetic interaction between ethanol and finasteride. Alcohol is metabolized primarily through alcohol dehydrogenase and CYP2E1, pathways that do not overlap with finasteride's CYP3A4 route [2]. Drinking a beer or a glass of wine while on finasteride will not alter drug levels.

The concern is pharmacodynamic and indirect. Chronic heavy alcohol intake (defined by the NIAAA as more than 14 drinks per week for men) elevates circulating estradiol through increased aromatase activity and impaired hepatic estrogen clearance [16]. Finasteride already shifts the testosterone-to-DHT ratio by blocking 5-alpha reductase; excess estrogen from alcohol compounds the hormonal imbalance. Clinically, this can manifest as worsened gynecomastia risk and diminished hair regrowth. A 2019 retrospective analysis of 1,874 men on finasteride for AGA found that those reporting heavy alcohol use were 1.7 times more likely to discontinue treatment due to side effects compared to light or non-drinkers (OR 1.72, 95% CI 1.18 to 2.51) [17].

Moderate alcohol consumption (up to 7 drinks per week) has not been shown to impair finasteride's efficacy in any published cohort study.

Green Tea, EGCG, and 5-Alpha Reductase

Epigallocatechin-3-gallate (EGCG), the primary catechin in green tea, has demonstrated 5-alpha reductase inhibition in cell culture models [18]. A 2013 study in the Journal of Nutritional Biochemistry found that EGCG reduced DHT formation in human prostate homogenates by approximately 40% at high concentrations (100 μM) [18]. These concentrations are not achievable through normal tea consumption, and only marginally approached with high-dose EGCG capsules (800 to 1,600 mg/day).

Drinking 2 to 4 cups of green tea daily while on finasteride poses no recognized risk. The catechin levels reached in plasma (typically <1 μM after a standard cup) are orders of magnitude below the threshold for meaningful 5-alpha reductase inhibition. High-dose EGCG supplements (above 800 mg/day), however, carry hepatotoxicity risk: the European Food Safety Authority concluded in 2018 that EGCG doses at or above 800 mg/day from supplements "may be linked to liver injury" [19]. This hepatotoxicity concern, not the 5-alpha reductase overlap, is the primary reason to exercise caution with mega-dose green tea extract.

Soy Isoflavones and Phytoestrogens

Soy foods contain genistein and daidzein, isoflavones with weak estrogenic activity. In vitro, genistein inhibits 5-alpha reductase type I at concentrations of 10 to 50 μM [20]. Normal dietary soy intake (one to two servings of tofu or soy milk daily) produces plasma isoflavone levels well below this threshold (typically 0.1 to 2 μM).

A 2009 meta-analysis of 47 soy intervention studies concluded that soy foods do not significantly alter testosterone, free testosterone, or SHBG levels in men [20]. The clinical relevance of soy isoflavone interaction with finasteride is negligible at dietary intake levels. Men taking concentrated isoflavone supplements (40 mg or more of isolated genistein daily) lack safety data on co-administration with finasteride. The conservative approach is to rely on dietary soy rather than isolated isoflavone capsules.

Building a Safe Supplement Stack with Finasteride

The most practical approach is to separate supplements into three categories for patients on finasteride. First, supplements with no known interaction and general safety: vitamin D3 (1,000 to 2,000 IU/day), omega-3 fatty acids, magnesium, and standard multivitamins at RDA doses. Second, supplements requiring awareness but not avoidance: zinc (15 to 30 mg/day, monitor copper), biotin (stop 72 hours before labs), and moderate green tea consumption. Third, supplements to avoid or use only under physician supervision: saw palmetto, St. John's Wort, high-dose EGCG (above 800 mg/day), and concentrated isoflavone capsules.

The Endocrine Society recommends that patients disclose all supplements and herbal products to their prescriber, noting that "herbal preparations are drugs with variable potency and potential for interaction" [6]. Finasteride's long track record of safety rests on data from patients in clinical trials who were not simultaneously taking unregulated herbal 5-alpha reductase inhibitors.

Every patient on finasteride should bring a complete supplement list to each prescriber visit. Dose changes in finasteride should never be self-adjusted to "compensate" for a supplement being added or removed. PSA screening requires biotin washout of at least 72 hours [11].